Avastin Passes Tox Test In Colon Cancer
This article was originally published in The Pink Sheet Daily
Drug and control arms in C-08 study of Genentech drug turn out the same.
You may also be interested in...
CHICAGO - First placebo-controlled, double-blinded evidence for bevacizumab in first-line metastatic breast cancer presented at ASCO.
Revised timeline for the C-08 trial does not change Genentech’s assessment of probability of success.
Accelerated approval wants more clinical proof.